Blood Culture Tests Market Share, Size, Trends and Research Report 2016

Submitted by: Submitted by

Views: 10

Words: 678

Pages: 3

Category: Business and Industry

Date Submitted: 09/01/2016 04:09 AM

Report This Essay

Technavio Announces the Publication of its Research Report Global Blood Culture Tests Market 2016-2020

Technavio recognizes the following companies as the key players in the global blood culture tests market: BioMérieux, BD, Roche Diagnostics, ThermoFisher Scientific, and Cepheid.

Other Prominent Vendors in the market are: AB Sciex, AdvanDX, Alere, Beckman Coulter, Bruker, Dade Behring¸ Eurogentec, IRIDICA, Nanosphere, and Siemens.

Browse full report with TOC@ https://marketreportscenter.com/reports/374194/global-blood-culture-tests-market-2016-2020

Commenting on the report, an analyst from Technavios team said: Demand for rapid diagnostic tests will be a key trend for market growth. Rapid identification of microorganisms in clinical laboratories is of great value for the selection of optimal patient management strategies for inhibiting bacteria, viruses, fungi, mycobacteria, and parasites. There is a critical need for new technologies in the area of clinical microbiology, particularly for detecting BSIs that are responsible for the highest number of deaths worldwide. Rapid diagnostics tests offer rapid identification of pathogens, are cost-effective to a certain extent, and help in the effective targeting of antimicrobial therapy in hospitals.”

According to the report, use of automated blood culture systems will be a key driver for market growth. Blood culture tests that involve most of the microbiological studies are the second-most common procedure performed in medical settings to detect BSIs. Advanced automated systems such as BS's BacT/ALERT system, AccuMed International's ESP Culture system II, and Cepheid's GeneXpert system used for these tests help reduce the hands-on time, minimize infection detection time, and are easy to use. Conventional systems often used to provide false-positive results, which led to the development of advanced devices that have helped reduce false-positive results by 10%. These advanced systems have also reduced the...